
Caitlin Cox
News Editor at TCTMD
News Editor @TCTMD | Associate Director, Editorial Content @CRFheart | Knitter & Nerd | Winner of the 2020 @NIHCMfoundation Trade Journalism Award | She/Her
Articles
-
2 days ago |
tctmd.com | Caitlin Cox
This explains at least some of the racial/ethnic gaps in survival, researchers say. Harder to pinpoint is exactly why practices differ. Emergency medical services (EMS) agencies that serve predominantly Black/Hispanic areas differ in their approaches to out-of-hospital cardiac arrest (OHCA) compared with those serving mostly white populations, survey data show.
-
1 week ago |
tctmd.com | Caitlin Cox
News Opinion Editor's Corner Our most-read articles explore “occlusion MI” versus STEMI, TAVI in asymptomatic AS, and highlights from recent conferences. For May, TCTMD’s top 10 stories highlight the field’s greatest hits—TAVI in asymptomatic patients, the vagaries of statin decision-making, embolic protection woes, the latest on SGLT2 inhibitors, pulsed-field ablation safety, and more.
-
1 week ago |
tctmd.com | Caitlin Cox
Relying on iFR/FFR values from the LCx alone could mean many patients with left main disease miss out on revascularization. For patients with isolated left main (LM) coronary artery disease, pressure-based physiological testing—whether by fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR)—reveals different findings based on the territory in which the assessment is done, new data show.
-
1 week ago |
tctmd.com | Caitlin Cox
Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care. Many patients referred for specialty care to address long-COVID symptoms have subtle evidence of inflammation and other cardiopulmonary abnormalities that can be detected with advanced imaging, a single-center study shows.
-
2 weeks ago |
tctmd.com | Caitlin Cox
As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of time. Debates over which transcatheter valves work best in small aortic annuli are being rekindled by new observational data—like the SMART trial before it, the IMPPACT TAVR registry shows no mortality difference between balloon-expandable and self-expanding devices a few years after treatment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 4K
- DMs Open
- No

RT @TCTMD: In this #OnRecord, @TCTMD_Caitlin sits down with @_WayneBatchelor and @HadleyWilsonMD to discuss the widespread impact of the cu…

RT @HanCardiomd: Phase 3 trial of oral #Orforglipron ; lowering A1C by an average of 1.3% to 1.6% across doses Once-daily oral pill reduce…

RT @pash22: Reinterventions Rare Yet Predictable After TAVI, French Registries study by @nicolasdumonte1 et al show https://t.co/BcoWkDCSmo…